PNU-120596 |
PNU-120596 : Type II Positive allosteric modulator of CHRNA7
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CHRNA7 |
|
Type II Positive allosteric modulator
1 -5 μM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
Whole-cell voltage clamp of cDNA injected Xenopus Oocytes.
Selectivity Assessment Description:
No detectable modulation of human α4β2, α3β4, or α9α10 nicotinic acetylcholine receptors, at 50 μM, ...
Potency Cellular
In Vitro
CHRNA7
Mode of Action: Type II Positive allosteric modulator
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1523/JNEUROSCI.5269-04.2005
In Vivo Validations
Rat
Dose: 1 mg/kg
Route of delivery:
Intravenous
Organ of interest (O):
Brain
DOI Reference: 10.1523/JNEUROSCI.5269-04.2005
Orthogonal Probes def
canSAR1809441
Notes: EC50 6.2 μM at 100 μM ACh, whole cell voltage clamp, cDNA injected Xenopus oocytes. DOI: 10.1073/pnas.1017975108
METHYLLYCACONITINE
Notes: General nicotinic antagonist - additional treatment with methyllycaconitine recommended as a negative control.
Chemical Information
| Molecular Formula | C13H14ClN3O4 |
| SMILEs | COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl |
| InChI | InChI=1S/C13H14ClN3O4/c1-7-4-12(17-21-7)16-13(18)15-9-5-8(14)10(19-2)6-11(9)20-3/h4-6H,1-3H3,(H2,15,16,17,18) |
| Molecular weight | 311.07 Da |
| AlogP | 3.297620000000001 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 35 |